baber/WOPTO huggingface dataset:
Patent AT-E225008-T1 (AT)
Inventor: LUH JOACHIM
IPC: F16H9/00
Filed: 1999-12-18
Granted: 2002-10-15
Abstract: A hydraulic controller (10, 10a, 10b) for a continuously variable transmission (12) is proposed. Using a pump (42), the delivery chambers (24, 26) of a first and second adjusting device (14, 16) are acted upon to alter the transmission ratio of the transmission (12). The valve (36, 36a, 36b), which can be controlled using a pressure drop created at a throttle position (50), serves to control the pressure in the delivery chamber (24). According to the invention, additional means are provided to prevent an adjustment of the transmission (12) in the "low" direction in the (N) operating state and, as necessary, in the (P) and (N) operating states.
Patent AT-E279937-T1 (AT)
Inventor: WHITEHOUSE MARTHA JO
IPC: A61K38/00
Filed: 1999-08-27
Granted: 2004-11-15
Abstract: The present invention has multiple aspects. In particular, in one aspect, the present invention is directed to a unit dose composition comprising 0.2 µg/kg to 48 µg/kg of an FGF-2 of SEQ ID NO: 2, or an angiogenically active fragment or mutein thereof in a pharmaceutically acceptable carrier. In another aspect, the present invention is directed to a method for treating a human patient for coronary artery disease, comprising administering into one or more coronary vessels or a peripheral vein of a human patient in need of treatment for coronary artery disease a safe and angiogenically effective dose of a recombinant FGF-2, or an angiogenically active fragment or mutein thereof. The single unit dose composition of the present invention provides an angiogenic effect in a human CAD patient that lasts six months before re-treatment is required. In another aspect, the present invention is directed to a method of administration which optimizes patient's safety. In this embodiment, fluids, heparin and/or rate of infusion all play a role. In another aspect, the present invention is directed to a pharmaceutical composition comprising a therapeutically effective amount of FGF-2, alone or in combination with heparin, in a therapeutically effective carrier. The magnitude and duration of benefit were unexpected; in addition benefit with the IV route was unexpected.
Patent DE-1194641-T1 (DE)
Inventor: JOKINEN REIJO
IPC: F26B13/20
Filed: 2000-02-21
Abstract: Cylindrical drying rolls are provided over which a web is passed along with a support fabric. A throttling unit provided at short distance from opening nip in air blow box equipped at the side of fabric, divides negative pressure space formed between upper and lower sealing units into regions respectively of intensified and smaller negative pressures.  The air blow box extends along the entire width of web. The air blowing device is arranged on that side of support fabric, which is away from the roll (10), mainly at the opening nip between the support fabric and the roll so that it extends from the nip to at least a short distance forward in support fabric travel direction. The sealing units include nozzles, or mechanical seals, being transversal with respect to web conveyance direction. The upper sealing unit (36) is a nozzle arranged in blow box, close to support fabric, for blowing air jets away from the negative pressure space formed between the support fabric and blow box. The lower sealing element is arranged close to support fabric or the roll (14) turning the support fabric at a distance from opening nip. A suction orifice (54) is provided between the upper sealing nozzle and throttling unit, and is connected to suction device to increase negative pressure in the region (34'). The upper sealing nozzle is arranged close to disengaging point (40) between drying roll and support fabric. The lower sealing nozzle is arranged close to closing nip between turn roll and support fabric, so that air jet from the lower nozzle is discharged from closing nip, from the region (34) and from the pocket (20) formed between the drying rolls. The throttling unit has convex surface which guides the air jets away from intensified negative pressure region, using the Coanda effect. A guide plate is arranged between throttling unit and closing nip, to prevent external ejection of air with the ejecting nozzle from reaching the closing nip. The throttling unit has air flow restriction unit extending across the web and mounted resiliently or pivotably in blow box in order to maintain intensified pressure in the region (34). The throttling unit extends to a distance to be at a distance of 10 mm from the support fabric. The region (34) has length 100-200 mm and upper and sealing nozzle is at a distance of about 70 mm from the disengaging point of support fabric. The throttling unit is at a distance of about 100 mm from the disengaging point.
Patent DE-10847631-T1 (DE)
Title: Vertikalachsen-Windturbine mit Geschwindigkeitsregulierung und Windschutzsystem
Inventor: Tarik Ozkul
IPC: F03D3/02
Filed: 2010-11-22
Abstract: Energieerzeugende Windturbine mit vertikaler Achse mit einziehbaren Flügeln, wobei der Einziehgrad der Flügel durch einen Satz von Drähten eingestellt wird, die mit der Oberseite und der Unterseite der Flügel verbunden sind, welche mit der zentralen Welle derart verbunden sind, dass die Drähte durch die zentrale Drehwelle mittels Rollen zum Generatorgehäuse geführt werden, das an der Basis der zentralen Drehwelle angeordnet ist, wobei die Länge der Drähte gesteuert wird, indem die Drähte durch einen Betätigungsmotor eingezogen oder ausgelassen werden.
Patent DE-14425072-T1 (DE)
Title: Fensterscheibe
Inventor: BERTOLINI ALBERTO
IPC: B60J1/00
Filed: 2014-06-13
Abstract: Fensterscheibe, insbesondere eine Windschutzscheibe (1) eines Fahrzeugs wie einem Auto, gekennzeichnet durch mindestens eine elektronische Elektrolumineszenz-Dünnfilm-Anzeige (7).
Patent DE-96508-T1 (DE)
IPC: C04B35/04
Filed: 1983-05-24
Abstract: The unburnt refractory corn prises fine magnesia as a main constituent and significantiy differs from prior art refractories in that the maximum grain dia meter of the fine magnesia is 1.5 mm and in that magnesia having a grain diameter of 0.3 to 1.5 mm comprises at most 30% by weight of the refractory raw materials. By so limiting the particle size, a refractory having high compactness is obtained, as indicated by a high bulk density and low air permeability. The weight ratio of graphite to magnesium fine powder (particle size at most 0.3 mm) is from 2.5:1 to 0.4:1. The refractory does not crack when subjected to pressure at the time of moulding and has excellent resistance to corrosion and oxidation. It prererably comprises 100 parts by weight of the refractory raw materials and 1 to 6 parts by weight of an additive, selected from Al, Si, B4C, and SiC.
Patent DE-233669-T1 (DE)
IPC: H04B15/00
Filed: 1987-02-04
Abstract: Device for establishing such a galvanic connection between conductors of a first batch and conductors of a second batch that on the one hand signal transmission between the two batches can take place undisturbed, and on the other hand transmission consequent on inducing electro-magnetic radiation will be blocked in two respects. High voltage induced in the conductors of the first batch consequent on high-energetic radiation, which manifests itself as a pulse, is reduced in stages to a relatively low residual voltage on the conductors of the second batch. Besides voltages induced either in the conductors of the first batch or in the conductors of the second batch, consequent on electromagnetic radiation having a signal character, are strongly reduced, in such a way that the conductors of the relevant other batch (either the second or the first) will not cause a detectable corresponding radiation. For that purpose an LD-filter configuration with one or two T-sections connected in cascade has been connected between each pair of corresponding conductors. In one of these T-sections a coil, which also forms part of a high- voltage reducing section, has been utilized. The device is mounted in a housing, which blocks electromagnetic radiation and can be fixed to a wall of a Faraday cage room in such a way that an opening in that wall will be closed. In this manner electric conductors extending to the interior of the Faraday cage room can be connected, in the desired way, to electric conductors establishing a connection with the outer world.
Patent DE-841016-T1 (DE)
Inventor: CABANIS LOUIS
IPC: A43B5/16
Filed: 1997-11-04
Abstract: Assembly comprises creating a first sub-assembly by joining together an upper (11) which is at least partially supple and an inner sole (13) using nails (15), and then making a second sub-assembly by adding an outer sole (2), which is fixed in place by rivets (18). The second sub-assembly is then joined to the rigid frame (1) by nuts and bolts (5a, 5b). The second sub-assembly can be adjusted relative to the frame by means of a transverse elongated slot (1b) for the front bolt.
Patent ES-2184656-T1 (ES)
Title: Metodo para caracterizar el aspecto de un objeto particular, para predecir el aspecto de un objeto, y para fabricar un objeto que tiene un aspecto predeterminado, que opcionalmente ha sido determinado sobre la base de un objeto de referencia.
Inventor: TORFS JAN C
IPC: G01N21/84
Filed: 2000-11-20
Abstract: Un método para caracterizar, por medio de una medición, el aspecto de uno bjeto o, más particularmente, la contribución de la superficie al aspecto de un objeto, caracterizado porque la contribución de la superficie al aspecto, o la reflexión de la superficie k1(w,h,i), se calcula partiendo de al menos un valor de reflectancia Rm(w,h,i) que se mide para al menos una frecuencia de luz w; un ángulo de visión predeterminado (h); y al menos un ángulo de iluminación predeterminado (i).
Patent ES-2065863-T1 (ES)
Title: Ensayo del virus de la hepatitis c.
Inventor: SIMMONDS PETER
IPC: C07K16/00
Filed: 1992-11-20
Abstract: SE HAN IDENTIFICADO Y SECUENCIADO NUEVOS ESTILOS DEL VIRUS DE LA HEPATITIS C (HCV), REFERENCIADOS COMO HCV-3 Y HCV-4. REGIONES ANTIGENICAS DE POLIPEPTIDOS DEL HCV-2, HCV-3 Y HCV-4 HAN SIDO IDENTIFICADAS. SE DESCRIBEN INMUNOENSAYOS PARA EL HCV Y ANTICUERPOS PARA EL MISMO, QUE PERMITEN UNA TAMIZACION MAS COMPLETA DE LA MUESTRAS DE SANGRE PARA EL HCV Y QUE PERMITEN LA GENOTIPIFICACION DEL HCV.
Patent ES-2122950-T1 (ES)
Title: Aparato de auto calibrado del sistema de analisis biologico.
Inventor: LEE SHIH-JONG J
IPC: G06V10/32
Filed: 1995-09-08
Abstract: SE OBTIENE UNA INFORMACION DE REFERENCIA (15) DE UNA PLATINA BIOLOGICA (11). LA INFORMACION DE REFERENCIA (15) NORMALIZA LAS CARACTERISTICAS DEL OBJETO MEDIDAS (19). LA MEDIDA DE LAS CARACTERISTICAS CALIBRADAS (21), NO BASADA EN MEDIDAS ABSOLUTAS, SE AUTOAJUSTA PARA ADAPTARSE AL LA SITUACION DE CADA PLATINA (11). CADA PLATINA (11) SE CARACTERIZA POR LA INFORMACION DE REFERENCIA (15). LA INFORMACION DE REFERENCIA PUEDE SER DIFERENTE DE PLATINA A PLATINA A CAUSA DE LAS VARIACIONES EN LA PREPARACION. LAS CARACTERISTICAS CALIBRADAS (21) NO MOSTRARAN VARIACIONES INTERPLATINAS. ADEMAS, LA INFORMACION DE REFERENCIA (15) PROPORCIONA UNA INDICACION BUENA DE LA CONDICION DE LA PLATINA COMO OSCURECIDA POR MANCHAS, SECAS POR AIRE, ETC., QUE SE PUEDE UTILIZAR COMO CARACTERISTICAS DE LA PLATINA (21) PARA LA CLASIFICACION DEL ESPECIMEN. NO SE REQUIERE NINGUNA ALTERACION DE LA PRACTICA ACTUAL DE LA PREPARACION DEL ESPECIMEN. LAS MUCHAS CARACTERISTICAS DEPENDIENTES DEL CONTEXTO DE LA PLATINA (21) MEJORAN LAPRECISION DE LA CLASIFICACION DE LOS OBJETOS EN EL ESPECIMEN.
Patent ES-2141690-T1 (ES)
Title: Optimizador del consumo de combustible y reductor de las emisiones de dioxido de carbono basado en un sistema de compensacion del vacio de aire por un liquido.
Inventor: DE LIMA C TITO
IPC: F02M33/00
Filed: 1996-12-19
Abstract: UN RECEPTACULO SOBREALIMENTADOR (1), UNA BOQUILLA DE ADMISION (10A) PARA EL AIRE QUE ENTRA EN EL RECEPTACULO (1) Y UNA BOQUILLA DE DESCARGA (12V) PARA EL AIRE QUE SALE DEL RECEPTACULO (1), UNA MASA DE LIQUIDO (14) DENTRO DEL CUERPO DEL RECEPTACULO (1), QUEDANDO LA MASA DE LIQUIDO (4) A UNA CIERTA DISTANCIA DE LA BOQUILLA DE ADMISION (10A) Y LA BOQUILLA DE DESCARGA (12V), UNA PLURALIDAD DE DEFLECTORES (11A-11D, 15A-15E) COLOCADOS DENTRO DE Y ACOPLADOS AL CUERPO DE RECEPTACULO QUE FORMAN UNOS CONDUCTOS DE PASO A TRAVES DE LOS CUALES CIRCULA EL AIRE, ESTANDO AL MENOS UNO DE LOS DEFLECTORES PARCIALMENTE SUMERGIDO EN LA MASA DE LIQUIDO (14). EL AIRE PASA ALREDEDOR DE LOS DEFLECTORES HASTA LA MASA DE LIQUIDO (14) Y UN VACIO PROCEDENTE DE UN COLECTOR DE ADMISION EJERCE UNA INFLUENCIA EN EL, FORMANDO EL AIRE BURBUJAS EN EL LIQUIDO Y ABANDONANDO LA MASA DE LIQUIDO (14) BAJO VACIO Y PASA A TRAVES DE LOS CONDUCTOS DE PASO (12) QUE HAY FORMADOS ENTRE LOS DEFLECTORES, Y SALE DEL RECEPTACULO SOBREALIMENTADOR (1) A TRAVES DE LA BOQUILLA DE DESCARGA (12V) QUE HAY CONECTADA AL COLECTOR DE ADMISION DE UN MOTOR DE COMBUSTION INTERNA.
Patent CY-1107549-T1 (CY)
Title: Επικαλυψη πολυμepους για ιατρικες συσκευες
Inventor: RYPACEK FRANTISEK
IPC: A61L31/00
Filed: 2007-01-31
Abstract: Παρέχονται επικαλύψεις στις οποίες μπορεί να ενεργοποιούνται επιφάνειες με σύνδεση ομοιοπολικώς ενός παραγώγου σιλανίου (Α) στην επιφάνεια του μετάλλου, σύνδεση ομοιοπολικώς ενός πολυμερούς λακτόνης (Β) προς το παράγωγο σιλανίου με in situ πολυμερισμό διάνοιξης δακτυλίου και απόοθεση τουλάχιστον μιας στιβάδας πολυμερούς (C) επί της συνδεδεμένης λακτόνης. Βιολογικώς δραστικοί παράγοντες μπορεί να αποτίθενται με τις στιβάδες πολυεστέρα. Τέτοιες επικαλυμμένες επιφάνειες μπορεί να είναι χρήσιμες σε ιατρικές συσκευές, συγκεκριμένα stents.
Patent CY-1108811-T1 (CY)
Inventor: XIAOHU DAI DR
IPC: C02F1/00
Filed: 2009-02-18
Abstract: In a process to extract potable water from water effluent, the water effluent is subject to preliminary sedimentation, and then treated in an intermediate biological process, followed by filtration. The intermediate biological process takes place in a fluidised bed reactor. The filtration stage is a micro-sieve, followed by immediate disinfection. The first-stage treatment consists of one or more flocculation followed by a lamella screen separator and surrender to the fluidised bed reactor. The fluidised bed reactor has plastic grains with a specific surface area of 800 and 1200 m(2/m(3. The micro-sieve is a steel gauze with a 20-40 m mesh drum. The disinfection process is by ultraviolet radiation.
Patent CY-1109679-T1 (CY)
Inventor: VERMEULEN RENE
IPC: F16M7/00
Filed: 2009-11-25
Abstract: The present invention relates to an adjustable foot for setting up equipment in alignment. The adjustable foot comprises an annular element provided with an axial bore with internal screw thread. The adjustable foot furthermore comprises a shaft element provided with external screw thread matching the internal screw thread. When screwed into the bore, this shaft element can be adjusted in the axial direction with respect to the annular element by turning with respect to the annular element. The adjustable foot furthermore comprises a support part, provided on the annular element or shaft element as well as a washer. The washer and the support part are each provided with a convex respectively concave surface having essentially the same radius of curvature, such that the angle of the washer with respect to the support part can be adjusted. According to the invention the top surface of the annular element is made to slope downwards in the radially outward direction. According to the invention the adjustable foot furthermore comprises a cap with a diameter greater than that of the internal screw thread. According to a further aspect, the invention relates to a combination of an adjustable foot according to the invention, a substructure and equipment set up in alignment on said substructure, as well as an anchor bolt, wherein the equipment is anchored to the substructure by means of the anchor bolt, with the adjustable foot between them.
Patent CY-1110175-T1 (CY)
Inventor: DURANTON RENÉ
IPC: H01F38/14
Filed: 2010-07-06
Abstract: The invention concerns a so-called galvanic insulation device for coupling two electrical circuits used both for transporting direct or low frequency current and for transmitting medium or high frequency signals. Said device comprises two primary and/or secondary coupling circuits (E1, E2), separated from each other by an electrically insulating material (R) through which the coupling is produced, such that it is possible to visually ascertain the physical separation of the two circuits (E1, E2).
Patent CY-1111430-T1 (CY)
Title: Χρηση της αγομελατινης για τη ληψη φαρμακων που προοριζονται για τη θεραπεια του συνδρομου smith magenis
Inventor: MOCAER ELISABETH
IPC: A61P25/00
Filed: 2011-04-27
Abstract: Η παρούσα εφεύρεση αναφέρεται στη χρήση της αγομελατίνης ή Ν-[2-(7-μεθοξυ-1-ναφθυλ)αιθυλ]ακεταμιδίου για τη λήψη φαρμάκων που προορίζονται για τη θεραπεία του συνδρόμου Smith Magenis.
Patent CY-1113491-T1 (CY)
Title: Φαρμακοτεχνικες μορφες για θεραπευτικη χορηγηση της διεγερτικης ορμονης του θυρεοειδους (tsh)
Inventor: CLARK ELIANA
IPC: A61P5/14
Filed: 2012-12-18
Abstract: Αυτή η αποκάλυψη σχετίζεται γενικώς με καινοφανείς φαρμακοτεχνικές μόρφες περιέχοντας το δραστικό συστατικό διεγερτική ορμόνη του θυρεοειδούς (TSH) έχοντας τροποποιημένα φαρμακοκινητικά προφίλ εν συγκρίσει με τις φαρμακοτεχνίκες μορφές της πρότερης τεχνικής.
Patent CY-1113717-T1 (CY)
Title: Μεθοδος για την παρασκευη [(1r),2s]-2-αμινοπροπιονικου 2-[4-(4-φθορο-2-μεθυλο-1η-ινδολ-5-υλοξυ)-5-μεθυλπυρρολο]2,1-f[1,2,4]τριαζιν-6-υλοξυ]-1-μεθυλαιθυλεστερα
Inventor: CRISPINO GERARD A
IPC: C07D487/04
Filed: 2013-02-22
Abstract: Η εφεύρεση αφορά βελτιωμένη διαδικασία για την παρασκευή [(1R),2S]-2-αμινοπροπιονικού 2-[4-(4-φθορο-2-μεθυλ-1Η-ινδολ-5-υλοξυ)-5-μεθυλπυρρολο [2,1-F][1,2,4] τριαζιν-6-υλοξυ]-1-μεθυλαιθυλεστέρα του τύπου (I). Η Ένωση (I) έχει αποδειχθεί χρήσιμη εις τη θεραπευτική αγωγή ορισμένων τύπων καρκίνου.
Patent CY-1122455-T1 (CY)
Title: Μεθοδος πιστοποιησης ενος ηλεκτρονικου μηνυματος που περιλαμβανει μια εμπιστευμενη ψηφιακη υπογραφη απο εναν φορεα εκμεταλλευσης τηλεπικοινωνιων
Inventor: SAPENA SOLER FRANCISCO
IPC: H04L29/06
Filed: 2020-01-08
Abstract: Το αντικείμενο της εφεύρεσης είναι μία μέθοδος για την πιστοποίηση ηλεκτρονικών μηνυμάτων με μία αναγνωρισμένη ηλεκτρονική υπογραφή όπου ένας φορέας εκμετάλλευσης τηλεπικοινωνιών πιστοποιεί την αποστολή ενός πιστοποιημένου ηλεκτρονικού μηνύματος εκ μέρους ενός χρήστη πελάτη του εν λόγω φορέα εκμετάλλευσης σε έναν έτερο χρήστη μη-πελάτη του φορέα εκμετάλλευσης τηλεπικοινωνιών, τηρώντας ανά πάσα στιγμή την αλυσίδα επιτήρησης και τις αρχικές αναγνωρισμένες ηλεκτρονικές υπογραφές κατά την εκ νέου αποστολή και την πιστοποίηση, δημιουργώντας ανά πάσα στιγμή αποδεικτικά στοιχεία της συναλλαγής, κατά έναν τέτοιο τρόπο ώστε να μπορεί να χρησιμοποιηθεί ως ενισχυμένο αποδεικτικό στοιχείο σε οποιοδήποτε δικαστήριο είτε ως αξιόπιστη απόδειξη μίας δεδομένης συναλλαγής.
Patent CY-1124400-T1 (CY)
Title: Σεισμικη γεωδαιτηση ταχειας ανιχνευσης 4d
Inventor: ALKHATIB HABIB
IPC: G01V1/30
Filed: 2021-07-13
Abstract: Μια μέθοδος για την παρακολούθηση μιας υπο-επιφάνειας κατά την διάρκεια μιας γεωδαίτησης 4 διαστάσεων (4D). Η μέθοδος περιλαμβάνει λήψη (1204) μιας περιοχής της υπο-επιφάνειας η οποία πρέπει να παρακολουθηθεί• ταυτοποίηση (1206) τοποθεσιών δέκτη και πηγής για τις συχνότητες περιοχής και πηγής που πρόκειται να εκπεμφθούν στην περιοχή με βάση την αντιστροφή της διαδικασίας μετανάστευσης ή την αναδρομική παρακολούθηση ακτίνας• εκτέλεση (1212) μιας ελαφράς βασικής γεωδαίτησης για την περιοχή• εκτέλεση (1208) μιας ελαφρός γεωδαιτικής παρακολούθησης για την περιοχή• και δημιουργία (1210) μιας εικόνας της περιοχής με βάση την σύγκριση (i) της ελαφράς βασικής γεωδαίτησης, και (ii) της ελαφράς γεωδαιτικής παρακολούθησης για την περιοχή.
Patent GR-880300103-T1 (GR)
Title: T7 dna polymerase
Inventor: STANLEY TABOR
IPC: G01N33/50
Filed: 1988-10-21
Abstract: The invention relates to methods of DNA sequencing including a method for determining the nucleotide base sequence of a DNA molecule, comprising providing the DNA molecule annealed with a primer molecule able to hybridize to the DNA molecule,   incubating the annealed mixture with a DNA polymerase, except reverse transcriptase, in the presence of four different deoxynucleoside triphosphates and a chain terminating agent which terminates DNA synthesis at a specific nucleotide base, the concentration of all four deoxynucleoside triphosphates at the start of said incubating being sufficient to allow DNA synthesis to continue until terminated by said agent. The DNA products of the incubating reaction are separated according to their size, so that at least a part of the nucleotide base sequence of the DNA molecule can be determined. In a furter embodiment the primer may be extended and labelled prior to the incubating reaction.
Patent HR-P20100031-T1 (HR)
Inventor: KEMPERMAN GERARDUS JOHANNES
IPC: C07D313/14
Filed: 2010-01-18
Abstract: Trans-aminokiselinski derivat, naznačen time što je to derivat formule I ili formule IIili enantiomer svakog trans-aminokiselinskog derivata sa suprotnom apsolutnom konfiguracijom, ili racemična smjesa svakog trans-aminokiselinskog derivata, ili njegova sol. Patent sadrži još 11 patentnih zahtjeva.
Patent HR-P20100604-T1 (HR)
Inventor: BENEDETTI YANNICK
IPC: C07D453/02
Filed: 2010-11-10
Abstract: Spoj prema formuli (I) naznačen time da je R1 heteroarilna ili arilna skupina, gdje su navedene heteroarilne ili arilne skupine po želji supstituirane s više skupina koje su odabrane iz halogenih atoma i (C1-C4)alkila, (C1-C4) alkoksi, (C3-C7)cikloalkila, arila, hidroksi, cijano, -NH2, -NO2 skupina; R2 predstavlja vodikov atom ili (C1-C4)alkilnu skupinu; R3 predstavljaskupinu  -(CH2)n-NR4R5 kod kojih jen jednak 2, 3 ili 4 iliR4 i R5 predstavljaju nezavisno jedan od drugog (C1-C4)alkilnu, (C3-C7) cikloalkilnu, ili alternativno R4 i R5 zajedno tvore, s atomom dušika koji ih nosi , (C3-C9) heterocikloalkilnu; ili skupinu-(CH2)mR6 kod koje jem jednak 0, 1, 2, 3 ili 4 iR6 predstavlja (C3-C9)heterocikloalkilnu skupinu koja sadrži najmanje jedan atom dušika i vezan na triazinski prsten atomom ugljika, gdje je (C3-C9)heterocikloalkilna skupina po želji supstituirana jednom ili više (C1-C4)alkilnih skupina; ili alternativno R2 i R3 tvore zajedno s atomom dušika koji ih nosi (C5-C9) heterocikloalkile koji sadrže 2 atoma dušika; uz uvjet da kada R1 predstavlja fenil, R4 i R5 istovremeno ne predstavljaju metil; u obliku lužine ili soli nastale dodatkom kiseline, kao i u obliku hidrata ili solvata. Patent sadrži još 14 patentnih zahtjeva.
Patent HR-P20100722-T1 (HR)
Title: Vertical axis wind turbine with control system and method of aerodynamic braking
Inventor: COLLING CLAUS
IPC: F03D7/02
Filed: 2010-12-27
Abstract: The controller comprises a component with a spring element to pre-stress an aerodynamic brake towards a run-in position. Another component has a mass element (5) to move out the aerodynamic brake through a centrifugal force caused through an adequate high rotation of a rotor blade-segment against the pre-stress of the spring element. A third component (7) has an actuator which is connected with the aerodynamic brake and actuated to move out the aerodynamic brake against the pre-stress of the spring element. An independent claim is included for a method for aerodynamic braking in a wind energy system.